Syndax Pharmaceuticals Statistics
Total Valuation
SNDX has a market cap or net worth of $1.44 billion. The enterprise value is $1.34 billion.
Important Dates
The last earnings date was Monday, November 3, 2025, after market close.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SNDX has 86.91 million shares outstanding. The number of shares has increased by 5.39% in one year.
| Current Share Class | 86.91M |
| Shares Outstanding | 86.91M |
| Shares Change (YoY) | +5.39% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 101.96% |
| Float | 73.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.92 |
| Forward PS | 4.87 |
| PB Ratio | 12.51 |
| P/TBV Ratio | 12.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.64, with a Debt / Equity ratio of 2.99.
| Current Ratio | 4.64 |
| Quick Ratio | 4.35 |
| Debt / Equity | 2.99 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.58 |
Financial Efficiency
Return on equity (ROE) is -129.32% and return on invested capital (ROIC) is -46.32%.
| Return on Equity (ROE) | -129.32% |
| Return on Assets (ROA) | -39.24% |
| Return on Invested Capital (ROIC) | -46.32% |
| Return on Capital Employed (ROCE) | -70.13% |
| Revenue Per Employee | $412,237 |
| Profits Per Employee | -$1.15M |
| Employee Count | 270 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.06% in the last 52 weeks. The beta is 0.52, so SNDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -0.06% |
| 50-Day Moving Average | 15.28 |
| 200-Day Moving Average | 13.04 |
| Relative Strength Index (RSI) | 59.66 |
| Average Volume (20 Days) | 3,915,380 |
Short Selling Information
The latest short interest is 25.34 million, so 29.16% of the outstanding shares have been sold short.
| Short Interest | 25.34M |
| Short Previous Month | 22.02M |
| Short % of Shares Out | 29.16% |
| Short % of Float | 34.59% |
| Short Ratio (days to cover) | 7.99 |
Income Statement
In the last 12 months, SNDX had revenue of $111.30 million and -$311.58 million in losses. Loss per share was -$3.60.
| Revenue | 111.30M |
| Gross Profit | -133.23M |
| Operating Income | -306.90M |
| Pretax Income | -311.58M |
| Net Income | -311.58M |
| EBITDA | -306.90M |
| EBIT | -306.90M |
| Loss Per Share | -$3.60 |
Full Income StatementBalance Sheet
The company has $454.17 million in cash and $345.43 million in debt, giving a net cash position of $108.74 million or $1.25 per share.
| Cash & Cash Equivalents | 454.17M |
| Total Debt | 345.43M |
| Net Cash | 108.74M |
| Net Cash Per Share | $1.25 |
| Equity (Book Value) | 115.43M |
| Book Value Per Share | 1.33 |
| Working Capital | 415.64M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$310.88 million and capital expenditures -$131,000, giving a free cash flow of -$311.01 million.
| Operating Cash Flow | -310.88M |
| Capital Expenditures | -131,000 |
| Free Cash Flow | -311.01M |
| FCF Per Share | -$3.58 |
Full Cash Flow StatementMargins
Gross margin is -119.70%, with operating and profit margins of -275.73% and -279.93%.
| Gross Margin | -119.70% |
| Operating Margin | -275.73% |
| Pretax Margin | -279.93% |
| Profit Margin | -279.93% |
| EBITDA Margin | -275.73% |
| EBIT Margin | -275.73% |
| FCF Margin | n/a |
Dividends & Yields
SNDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.39% |
| Shareholder Yield | -5.39% |
| Earnings Yield | -21.57% |
| FCF Yield | -21.53% |
Dividend DetailsAnalyst Forecast
The average price target for SNDX is $37.09, which is 123.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.09 |
| Price Target Difference | 123.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 110.38% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNDX has an Altman Z-Score of -2.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.75 |
| Piotroski F-Score | 3 |
